A SIMPLE KEY FOR PENTOBARBITAL OF SODIUM UNVEILED

pentobarbital decreases effects of sufentanil SL by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Intently. Coadministration of CYP3A4 inducers may possibly reduce sufentanil ranges and efficacy, potentially precipitating withdrawal syndrome in patients which have made physical dependence to sufentanil. Discontinuation